Radiological Approach to Asthma and COPD-The Role of Computed Tomography  by Nakano, Yasutaka et al.
Allergology International Vol 58, No3, 2009 www.jsaweb.jp 323
Radiological Approach to Asthma and
COPD-The Role of Computed
Tomography
Yasutaka Nakano1, Nguyen Van Tho1,2, Hideto Yamada1, Makoto Osawa1 and Taishi Nagao1
ABSTRACT
Asthma and chronic obstructive pulmonary disease (COPD) are among the most prevalent lung diseases. In
both asthma and COPD, airway inflammation leads to airway remodeling. Parenchyma of the lung is also influ-
enced by disease conditions. Airway wall thickeninglumen narrowing and parenchymal destruction occur in
COPD. In asthma, airway remodeling contributes to the lung parenchyma. Computed tomography (CT) has
been widely used as an imaging tool for lung diseases. With the technical advancement of CT, together with
the development of analysis software, it is now possible to analyze the lung parenchymal change and airway
remodeling quantitatively using CT. This article reviews the role of CT in assessing the lung structure and func-
tions of patients with asthma and COPD.
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INTRODUCTION
Asthma and chronic obstructive pulmonary disease
(COPD) are among the most prevalent lung diseases,
and these conditions contribute an enormous burden
of morbidity in Japan and globally.1-3 The pathophysi-
ologic mechanisms underlying asthma and COPD are
shown in Figure 1, 2.4 In both disorders, environ-
mental factors such as allergens, viruses, and bacte-
ria as well as personal, occupational, and atmospheric
pollution cause an exaggerated immuneinflamma-
tory response in genetically susceptible individuals.
The inflammatory response leads to airway remodel-
ing, which contributes to airway narrowing.4 In
asthma, although there is no destruction of lung pa-
renchyma, air trapping due to small airways influ-
ences the lung density assessed by computed to-
mography (CT).5 In COPD, lung parenchyma is de-
stroyed by inflammatory processes due to noxious
gases, and the lung density is reduced showing low
attenuation areas (LAAs).6,7 With technical advances
in CT together with the development of analytical
software, there is increasing interest in the radiologi-
cal assessment of asthma and COPD patients. In this
article, we describe the role of CT in the assessment
of structure and functions in patients with asthma and
COPD.
AIRWAY ASSESSMENT IN ASTHMA
Asthma is characterized by chronic airway inflamma-
tion which leads to airway remodeling and airway
wall thickening.5 A number of studies have shown
that the airway wall thickness in asthmatic patients is
increased, regardless of the severity of the dis-
ease.8-13 The degree of airway wall thickening has
been shown to be related to the duration of the dis-
ease, severity of disease, or the level of the airflow
limitation.10-14 Niimi and colleagues have shown that
the thickness of the right apical segmental bronchus,
adjusted for body surface area, increases as a func-
tion of the duration of diagnosed asthma.14 Niimi et
al. also showed that the airway wall area, corrected
by body surface area, was increased in relation to the
severity of the diseases (Fig. 3).10
The bronchial lumen area assessed using CT has
been shown to be both decreased and increased.15,16
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Fig. 1 Pathophysiologic schema for the development of asthma. 
Adapted from Nakano et al.4
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Fig. 2 Pathophysiologic schema for the development of COPD.
Adapted from Nakano et al.4
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In patients with asthma, most of the bronchi have
normal or decreased internal diameters; however, in
approximately 30-40% of adult patients with uncompli-
cated asthma, one or more bronchi are dilated.15
Lynch et al. reported that 77% of asthmatic patients
and 153 (36%) of 429 bronchi assessed in asthmatic
patients had an internal bronchial diameter to pulmo-
nary artery diameter ratio > 1.0, indicating dilatation
of the bronchus andor bronchiectasis.16
There are also a number of reports that compare
the luminal area of asthmatics with that of normal
subjects. Niimi et al. measured the right apical upper
lobe bronchus and found that there was no decrease
in luminal area in asthmatics compared with that in
normal subjects.10 However, Beigelman-Aubry et al.
reported that the bronchial cross-sectional areas were
significantly smaller than that in healthy volunteers.17
Okazawa et al. demonstrated that the degree of air-
way narrowing produced by inhaled methacholine in
asthmatics was the same as that in normal subjects.8
However, the same degree of narrowing was
achieved using a much lower dose of methacholine in
asthmatics than that in normal subjects. Goldin et al.
also used methacholine to show a greater decrease in
FEV1 and in the cross-sectional area of small
(<5 mm2) airways in asthmatics compared to those in
normal subjects.18 This controversy may be some-
what explained by the heterogeneity of airway re-
sponse. Using methacholine, King et al. reported that
airway narrowing is heterogeneous in the large air-
ways of asthmatics and normal subjects, and that this
heterogeneity is larger than that in control subjects.19
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Fig. 3 The distribution of wal area/body surface area in the control and 
four asthmatic groups. Bars represent means. The diference among 
groups was significant. Adapted from Nimi et al.10
Furthermore, there is also a report showing consider-
able regional heterogeneity in airway wall thickness
in the same individual.13
There are some reports that evaluated the relation-
ship between CT assessment of the airway wall thick-
ness and pathological measurements.12,13 Kasahara et
al. showed that the indices of airway wall thickness
on high-resolution CT (HRCT) scan (the ratio of wall
area to total airway area, and the ratio of wall thick-
ness to ideal luminal diameter) correlated with the
measurements of the thickening of the epithelial re-
ticular basement membrane obtained by bronchial bi-
opsy.12 Recently, Aysola and colleagues used
multidetector-row CT (MDCT) scans to demonstrate
that the airway epithelial thickness measure on the
biopsy sample correlated with the ratio of airway wall
thickness to total airway diameter.13
Therapeutic effect was also evaluated using
CT.14,20,21 Niimi et al. reported that 800 μg of inhaled
beclomethasone per day for 12 weeks resulted in a
significant decrease in the thickness of the right api-
cal segmental bronchus, although the decrease did
not return to the airway dimensions of an age-
matched asymptomatic control group.14 Lee et al. re-
ported that bronchial wall thickness was decreased
significantly both in near-fatal asthma (NFA) and non-
NFA groups after long-term (>6 months) treatment
with inhaled corticosteroids.20 Kurashima et al. also
used CT to evaluate the efficacy of inhaled corti-
costeroid (ICS) therapy and found that post ICS treat-
ment, airway wall thickness decreased in patients
with a duration of symptoms less than 3 years, and a
minor response was seen in patients with a duration
of symptoms ranging from 3 to 5 years. However,
there was no change in airway wall thickness in pa-
tients with asthma for more than 5 years.21
PARENCHYMAL ASSESSMENT IN ASTHMA
In contrast to the airway, there are a limited number
of studies that evaluate lung parenchyma in asthmatic
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patients by HRCT. The reason is that most asthmatic
patients do not demonstrate parenchymal abnormali-
ties during the stable stages. Asthma is mainly a
small airway obstructive disease; however, it may
manifest some parenchymal abnormalities such as
centrilobular micronodules, mosaic perfusion and air-
trapping in terms of chest CT.22 These observations
have been evaluated using CT.9,17,23-25
Laurent et al. evaluated lung abnormalities in 22 pa-
tients with stable moderate asthma and compared
with 12 healthy non-smokers and 10 healthy smokers
by HRCT.24 They found that the mosaic perfusion
pattern at full inspiration was observed in 23% of asth-
matics but not in normal controls. Mosaic perfusion
in asthma was probably due to hypoxic vasocontric-
tion or changes in regional lung inflation due to small
airway obstruction. They also found that air-trapping
scores in the independent zones were significantly
higher in asthmatic patients and healthy smokers
than in healthy non-smoking people. In asthmatic pa-
tients, air-trapping scores correlated with FEV1 and
FEF25-75%. This parenchymal abnormality was also
attributed to small airway obstruction in asthmatics.
Other parenchymal abnormalities (centrilobular mi-
cronodules, emphysema) were not detected in all
these asthmatic patients.
Using HECT, Ueda et al. evaluated mean lung den-
sity and LAA% (the ratio of LAAs to corresponding
lung area) at full inspiration and full expiration in 29
stable asthmatic patients.25 They found that the mean
lung density increased (from −886 HU to −769 HU)
and LAA% decreased (from 19.3% to 2.2%) in all pa-
tients during the expiratory phase compared with
that during the inspiratory phase. Expiratoryinspira-
tory (EI) ratios of LAA% and mean lung density
(MLD) correlated with disease severity, residual vol-
umetotal lung capacity (a functional measurement of
air trapping), and airway sensitivity, as well as with
FEV1, FEV1FVC and FEF25-75%.
The EI ratio of LAA% or MLD might reflect the
degree to which fully inhaled air is effectively exhaled
at full expiration or the degree of air trapping, a dy-
namic phenomenon occurring in the lungs of patients
with asthma because of small airways abnormalities.
CT has also been used for the evaluation of asthma
treatment. Goldin et al. used CT to compare the
therapeutic effect between an extra-fine beclometha-
sone dipropionate inhaler (hydrofluoroalkane-
beclomethasone dipropionate [HFA-BDP]) and a con-
ventional chlorofluorocarbon preparation (CFC-
BDP).26 Regional gas trapping assessed by CT dem-
onstrated that HFA-BDP showed a significant de-
crease in gas trapping after four weeks of treatment.
Mitsunobu and colleagues evaluated the therapeu-
tic effect in asthma using both MLD and the relative
lung area with an attenuation of <−950 HU (RA950).27
They found that both MLD and RA950 changed sig-
nificantly with administration of systemic glucocorti-
coid therapy. Changes in forced expiratory volume in
one second correlated significantly with those in both
MLD and RA950.
Another method of evaluating the heterogeneity in
asthmatic patients has also been reported. Mitsunobu
et al. used a power low analysis (fractal analysis) to
determine exponent D as a surrogate of the complex-
ity of the terminal airspace geometry.28 They also
used LAA% and found that LAA% differed significantly
between moderate and mild asthma, but D did not. In
mild and moderate asthma, a highly significant corre-
lation between LAA% and D was observed in patients
with a smoking history, but not in nonsmoking sub-
jects with asthma. They concluded that decreased D
is mostly related to emphysematous change, and
both measurements of LAA% and D may provide use-
ful information to characterize low attenuation areas
in subjects with asthma.
AIRWAY ASSESSMENT IN COPD
It has been reported that the important site of airflow
obstruction in COPD is the small airways.29-31 De-
spite technical advances in CT, the data obtained by
routine clinical scanning contain large errors in terms
of airway measurement.32 To determine whether the
dimensions of relatively large airways assessed using
computed tomography reflect small airway dimen-
sions measured histologically, Nakano et al. assessed
airway dimensions in non-obstructed or mild to mod-
erately obstructed patients following lobar resection
for peripheral tumor.33 They conclude that CT meas-
urements of airways with an internal perimeter (Pi) of
0.75 cm or more could be used to estimate the dimen-
sions of the small conducting airways, which are the
site of airway obstruction in chronic obstructive pul-
monary disease. These data suggest, at least for
COPD, that airway dimensions in the larger bronchi
could be used as surrogates for small airway dimen-
sions.
Nakano et al. measured the lung attenuation and
trunk of the apical bronchus of the right upper lobe in
114 smokers.34 They chose this bronchus because it
is usually cut in cross-section and can be reliably
identified on CT, thereby allowing comparison be-
tween individuals. They found that the LAA% and air-
way dimensions (the ratio of airway wall thickness to
total diameter (TD ratio) and the percentage wall
area [WA% = (WAAo) × 100])8,11,35 independently
correlated with measures of airflow obstruction. WA%
correlated with FEV1 % predicted, forced vital capac-
ity (FVC) % predicted and residual volume (RV)total
lung capacity (TLC), but not with lung diffusing ca-
pacity.34 Interestingly, the airway wall area increased
and lumen area decreased in COPD patients while
the airway area increased and lumen area did not
show any change in asthmatic patients.10,34 A differ-
ent pattern of remodeling shown by these two studies
may reflect fundamental differences in the inflamma-
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tory processes in asthma and COPD and could influ-
ence the reversibility of narrowing.4 Patel et al. inves-
tigated index cases of COPD and their smoking sib-
lings, and reported a similar result in a large group
(1,159 CT scans).36 They found that the airway wall
thickness correlated with pack-years smoked and
symptoms of chronic bronchitis. They also found that
there was independent familial aggregation of both
the emphysema and airway disease phenotypes of
COPD.
Berger et al. used CT to compare airway wall thick-
ness in nonsmokers with normal lung function to that
in smokers with and without COPD.37 They demon-
strated that in vivo normalized airway wall thickness
was larger in smokers with COPD than it was in
smokers or nonsmokers without COPD. Orlandi et al.
studied 42 COPD patients (20 with and 22 without
chronic bronchitis [CB]) and found that patients with
CB had a significantly higher WA% and significantly
lower LAA% than patients without CB.38 They con-
cluded that bronchial wall measurements differ be-
tween patients who have COPD with CB and those
who have COPD without CB.
Hasegawa et al. analyzed 52 patients with clinically
stable COPD.39 They firstly used three-dimensional
computed tomography to evaluate the airway dimen-
sions from the third to sixth generations of the apical
bronchus (B1) of the right upper lobe and anterior
basal bronchus (B8) of the right lower lobe. They
found that airway luminal area and WA% were signifi-
cantly correlated with FEV1 (% predicted) and the
correlation coefficients improved as the airways de-
creased in size from the third (segmental) to sixth
generations in both bronchi.39
Matsuoka and colleagues used inspiratory and ex-
piratory multislice CT to analyze the relationship be-
tween airflow limitation and airway dimensions from
the third to the fifth generation of bronchi in 50
COPD patients.40 They found that airway lumen
measured at expiratory CT was more closely related
to expiratory airflow measurements than lumen
measured at inspiratory CT. In addition, the changes
in airway luminal area between inspiration and expi-
ration were strongly related to airflow limitation.
Ohara et al. investigated the annual changes in air-
way dimensions and lung attenuation using CT in pa-
tients with COPD.41 They evaluated airway dimen-
sions of the basal segment bronchi and lung attenu-
ation on CT images in 38 patients. They found that
annual changes in the percentage of wall area (WA%
year) were inversely correlated with annual changes
in FEV1, while annual changes in LAA% were not cor-
related with decline in FEV1.
Recently, Coxson et al. compared optical coher-
ence tomography (OCT) measurements of airway di-
mensions with measurements assessed using CT
scans and lung function.42 They found that there was
a strong correlation between CT and OCT measure-
ments of the lumen and wall area. They also found
that OCT may be more sensitive in detecting small
airway wall changes that lead to FEV1 changes in in-
dividuals with obstructive airway disease.
The studies described above indicate that airway
measurements using CT are a useful and sensitive
method of evaluating airway wall thickeningremod-
eling in vivo.
PARENCHYMAL ASSESSMENT IN COPD
Computed tomography is superior to chest radiogra-
phy in demonstrating the presence, distribution, and
extent of emphysema.43 There have been a large
number of reports that evaluated the lung parenchy-
mal change in COPD patients. In patients with
COPD, LAAs have been reported to represent macro-
scopic and microscopic emphysematous changes in
the lung.6,7,44-50 In a study of lung specimens, Hruban
et al. assessed the degree of centrilobular emphy-
sema radiologically on a visual grading system based
on nonperipheral LAAs.44 They then compared the
pathological grade of centrilobular emphysema with
in vitro CT score and found a significant correlation
(r = 0.91). Other studies have shown a correlation be-
tween in vivo HRCT assessment of emphysema and
the pathological severity in the order of 0.7-0.9.45,48,51
Since visual assessment of emphysema on CT is
time-consuming and intra-inter- observer variability
is not negligible, an objective method using CT num-
bers (Hounsfield unit [HU]) has been ap-
plied.7,34,46,49,50,52-64 Most of the studies used a single
threshold value as the cut-off level between the nor-
mal lung density area and LAA. The threshold value
range has varied from −856 to −960 HU. Coxson et al.
and Nakano et al. used 6.0 mlgram, which corre-
sponds to −856 HU, and evaluated mild emphy-
sema.52,62 Bae et al. used −900 HU,53 while others
used −910 HU,7,54-56 −950 HU,46,49,56 or −960
HU.34,50,57-61,63,64 This discrepancy may be due to the
differences between CT machines with different
kinds of reconstruction algorithm or due to differ-
ences between conventional and high resolution CT
scanning.63
It is reported that the sensitivity of HRCT in detect-
ing early emphysematous change is low but its accu-
racy is higher than that of pulmonary function
tests.43,55,65,66 However, there are many reports that
have demonstrated significant relationships between
CT indices and pulmonary function tests in COPD pa-
tients.39,56,57,60,63,67-72 The extent of emphysema
(LAA%) in the whole lung correlated with pulmonary
function tests including FVC% predicted, FEV1% pre-
dicted, FEV1FVC, RVTLC and DLCOVA.34 The rela-
tionship between regional distribution of emphysema
and pulmonary function tests has also been evalu-
ated.55,62,63,73 Gurney et al. reported that patients with
predominantly upper zone emphysema show near
normal pulmonary function tests compared to that of
Nakano Y et al.
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Fig. 4 Relationship between WA% and extent of emphysema (LAA%) in 
94 COPD patients and 20 asymptomatic smokers. Horizontal line shows 
the mean +2SD of LAA% of the asymptomatic smokers. Vertical line shows 
the mean +2SD of WA% of the asymptomatic smokers. Using these cutof 
values, COPD patients can be divided into groups; the airway remodeling-
dominant group (high WA% and low LAA%), emphysema-dominant group 
(low WA% and high LAA%), and a mixed group (high WA% and high 
LAA%). Adapted from Nakano et al.4
those with predominantly lower zone emphysema.55
They also showed that the extent of emphysema in
the lower lung zone showed higher correlations with
DLCO than that in the upper lung zone, even though
the upper lung zone had more emphysema.55 Other
studies showed similar results.63,73 Nakano et al. re-
ported that LAA% in the lower zone correlated better
with FEV1FVC than LAA% in the upper zone.63 They
also evaluated the core (inner) and rind (outer) distri-
bution of emphysema and found that LAAs were
more often found in the inner segment of the lung
than in the outer segment, and the contribution of the
inner segment to pulmonary function tests may be
greater than that of the outer segment.63 This is in
agreement with Haraguchi et al., who concluded that
inner rather than outer emphysematous changes af-
fect pulmonary function.73 Nakano et al. also used
core and rind distribution of emphysema and evalu-
ated the outcome of lung volume reduction surgery
(LVRS) in COPD patients.62 They found that, al-
though emphysema exists more in the core of the
lung, a greater extent of severe emphysema in the
rind of the upper lung predicts greater benefit from
LVRS.62 The authors speculated that the analysis
based on the core and rind distribution of emphy-
sema identifies the lesions most accessible to re-
moval by LVRS.
Knudson et al. reported the usefulness of expira-
tion CT to evaluate emphysema.74 However,
Nishimura et al. showed that expiratory CT underes-
timates the degree of emphysema compared with
that estimated by inspiratory CT.75 Gevenois et al.
also reported that expiratory quantitative CT is not as
accurate as inspiratory CT for quantifying pulmonary
emphysema.49 The authors speculated that expira-
tory CT reflected air trapping more than reduction in
the alveolar wall surface.49 Matsuoka et al. used
paired inspiratoryexpiratory CT scans in a limited-
lung area and found that paired inspiratoryexpira-
tory CT measurements in the limited-lung without
emphysema correlated more closely with the pulmo-
nary function tests.76 They also reported that the den-
sitometric parameter of relative volume change calcu-
lated on paired inspiratory and expiratory MDCT us-
ing the threshold of −860 HU in limited lung corre-
lated closely with airway dysfunction in COPD re-
gardless of the degree of emphysema.77 The method
using paired inspiratoryexpiratory CT scans may be
better than that using expiratory CT alone.
Mishima et al. evaluated the size and numbers of
LAAs using fractal analysis.60 They found that the cu-
mulative size distribution of LAA clusters followed a
power law characterized by exponent D. They also
showed that D is a measure of the complexity of the
terminal airspace geometry. This study suggested
that D is a sensitive and powerful parameter for the
CT Approach to Asthma and COPD
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detection of the terminal airspace enlargement that
occurs in early emphysema.60
Nakano and colleagues evaluated 114 smokers (94
patients with COPD and 20 asymptomatic volun-
teers).34 They evaluated both airway dimensions
(WA%) and emphysema (LAA%) using CT. They
found that LAA% correlated significantly with FEV1,
FEV1FVC, PEFR, RVTLC, and DLCOVA but not
FVC. WA% correlated significantly with FVC, FEV1,
PEFR, and RVTLC but not FEV1FVC or DLCOVA.
They used multiple regression analysis and showed
that FVC, FEV1, FEV1FVC, PEFR, and RVTLC
were predicted better by a combination of LAA% and
WA% than by LAA% or WA% alone. However, WA%
did not add any predictive value to LAA% for DLCO
VA.34 They concluded that both CT measurements of
airway dimensions and emphysema are useful and
complementary in the evaluation of the lung of smok-
ers. Nakano et al. also found that they could divide
COPD patients into groups who showed predominant
loss of lung attenuation or thickening and narrowing
of the apical segmental bronchus using LAA% and
WA%.4 Although many subjects had both decreased
lung attenuation consistent with emphysema and air-
way wall thickening, there were individuals with simi-
lar degrees of obstruction whose abnormalities ap-
peared to be predominantly the result of airway re-
modeling and others in whom abnormalities ap-
peared to be predominantly related to the loss of lung
parenchyma. They used the mean +2 SD of LAA% in
asymptomatic smokers and the mean +2 SD of WA%
in asymptomatic smokers, and divided COPD pa-
tients into groups; airway remodeling-dominant
group (high WA% and low LAA%), emphysema-
dominant group (low WA% and high LAA%), and a
mixed group (high WA% and high LAA%) (Fig.4).4
Ogawa et al. used the same approach for male smok-
ers who have COPD and found that the body mass in-
dex (BMI) was significantly lower in those with a
higher LAA% phenotype (i.e., emphysema dominant
and mixed phenotypes).71 They also found that BMI
correlated with LAA% but not with WA%, and that
BMI was significantly lower in the emphysema domi-
nant phenotype than in the airway dominant pheno-
type. They concluded that a low BMI is associated
with the presence of emphysema, but not with airway
wall thickening.71 Other researchers also used CT to
find the relationship between emphysema and
BMI.78-82
CONCLUSIONS
CT has been widely used as an imaging tool for lung
diseases. However, as described here, it is possible to
analyze the lung parenchyma and airways quantita-
tively using digital data from CT. The information de-
rived from CT data may be useful in clarifying the
pathogenesis of lung diseases. The relationships be-
tween CT indices and biomarkers of inflammation
and repair in blood, bronchoalveolar lavage and ex-
haled breath condensate are important areas for addi-
tional investigation.83 Further studies are needed in
this area.
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